Octopus Second AIM VCT plc ("the Company")
29 October 2010
Purchase of own securities
Octopus Second AIM VCT plc announces that on 29 October 2010 the Company
purchased for cancellation 250,000 Ordinary shares at a price of 60.5p per
share. The Ordinary shares purchased represent 0.70% of the total number of
voting rights in the Company before the transaction.
Following this transaction, the issued share capital of the Company now consists
of 35,895,010 Ordinary shares with a nominal value of 0.01p each, with voting
rights. The Company holds no shares in Treasury.
For further enquiries, please contact:
Celia Whitten, Company Secretary
Octopus Investments Limited
Tel:Â 020 7710 2849
[HUG#1457348]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Octopus Second AIM VCT plc via Thomson Reuters ONE
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.